Dxcover https://validator.w3.org/feed/docs/rss2.html Unprecedented Early-Stage Cancer Detection Presented at AACR 2026 Dxcover Secures CE-IVDR Certification Privacy Policy Science & Evidence Resources Leadership Investors PANAROMIC™ Partner With Us Board Contact Tests US Lab Dxcover launches US operations to commercialize its AI-powered multiomic cancer detection test Newsroom Blog Ovarian Cancer Pancreatic Cancer Brain Cancer New Blood Test Helps GPs Manage Brain Scan Delays, Brings Field Forward Dxcover Strengthens Leadership with World-Class Scientific Advisors and Board Members Dxcover Announces Global Presentation Of First Real-World Evidence Demonstrating That Increased Tumour Size Is Associated With Higher Mortality In Patients With Brain Cancer ClinSpec Dx win Ready, Steady, Pitch! at Converge Challenge 2017 Glasgow to host SPEC2018 Conference ClinSpec Dx runners up in Converge Challenge 2017 Award season for ClinSpec Dx Brain Cancer Liquid Biopsy ClinSpec Dx installed at Edinburgh’s Western General Hospital Top 40 under 40 – The Analytical Scientist ClinSpec Dx pitch at EIE18 ClinSpec Dx co-founder named one of “20 women to watch” Evidence of ClinSpec Dx health economic benefit published in British Medical Journal OA SPEC 2018 conference in Glasgow ClinSpec Dx™ win the Moonshot award at the Global Game Changers ’18 ClinSpec Dx™ win Scottish Edge award and also presented with Higgs special award ClinSpec Diagnostics Spin-out Clinspec Dx win the Scottish Life Sciences Innovation award US and EU patent granted ClinSpec Dx are part of Tech Nation! About Preliminary results from brain cancer study published in Nature Communications KPMG Best British Tech Pioneer – ClinSpec Dx shortlisted The Rt Hon Boris Johnson MP says ClinSpec Diagnostics technology will save lives ClinSpec Dx receive £2.4m funding boost Cancer diagnostics firm completes £3.5M funding round ClinSpec Diagnostics rebrands as Dxcover and targets growth Dxcover Accelerates Growth With New Funding Round and Strengthens The Leadership Team Dxcover Limited appoints Operations Director The future of cancer diagnostics is now Home